Marketed in 68 countries across Europe, the Americas, Asia, and Oceania, Aerius is a globally distributed brand of desloratadine, classified as an H1-antihistamine for systemic use. Its broad international footprint makes it one of the more recognisable allergy brands a traveller or expatriate is likely to encounter on pharmacy shelves outside their home market.
Desloratadine is prescribed for the management of allergic conditions, including allergic rhinitis (commonly recognised as hay fever), chronic urticaria (hives), and related allergic skin presentations. The structured indication list further down this page details the registered uses recognised across the regulatory authorities where Aerius is sold, and the precise wording of those indications can vary from one national authority to another.
Because Aerius circulates so widely, travellers frequently come across it under the same brand name in markets as different as Australia, Chile, China, Canada, and Denmark. Even so, packaging, pack sizes, and whether the product is dispensed over the counter or by prescription differ between jurisdictions. The same active ingredient, desloratadine, is also marketed worldwide under a number of generic and alternative brand names, and a pharmacist in the destination country can confirm which products on the local shelf contain the same molecule.
Other medications in the H1-antihistamine class are sold in many of the same markets, with several second-generation antihistamines available as both prescription and non-prescription products depending on the country. They are not freely interchangeable, however — each molecule has its own profile, and a local pharmacist or physician is the right person to identify the appropriate option. Decisions about starting, stopping, or switching an antihistamine regimen are best made together with a healthcare provider who knows the patient's history.